Sitka Biopharma Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $3.1M
Latest Deal Amount
  • Investors
  • 3

Sitka Biopharma General Information

Description

Developer of a nano-particle polymer platform technology designed to improve drug absorption for cancer treatments. The company's platform increases absorption of drugs in difficult-to-penetrate tissues, and addresses the absorption challenges of intravesical chemotherapy for bladder cancer, and later intraperitoneal delivery for ovarian cancer, enabling caregivers to transform chemotherapies to benefit patients by enhancing drug efficacy and improving tolerability.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • 2405 Wesbrook Mall
  • Fourth Floor
  • Vancouver, British Columbia V6T 1Z3
  • Canada
+1 (604) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sitka Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 11-Feb-2019 $3.1M 00.00 Completed Pre-Clinical Trials
2. Seed Round 07-Aug-2016 00.00 00.00 Completed Pre-Clinical Trials
1. Spin-Off 03-Dec-2013 Completed Pre-Clinical Trials
To view Sitka Biopharma’s complete valuation and funding history, request access »

Sitka Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a nano-particle polymer platform technology designed to improve drug absorption for cancer treatments. The
Biotechnology
Vancouver, Canada
5 As of 2016
00.00
0000000000 0 00.00

000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
0000 00000000
Paris, France
00 As of 0000
000.00
00000000000 000.00

00000000

uis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur
000000000000000
Tokyo, Japan
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sitka Biopharma Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Horama Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
000000000000 00000 Venture Capital-Backed Tokyo, Japan 0 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Indianapolis, IN 0 000.00 00000000000 000.00
000 00000000000000 Venture Capital-Backed Debrecen, Hungary 00 00.000 0000000000 00.000
000000000000 Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
You’re viewing 5 of 34 competitors. Get the full list »

Sitka Biopharma Executive Team (4)

Name Title Board Seat Contact Info
Michael Parr Ph.D Co-Founder, President, Chief Scientific Officer & Board Member
Robert Geckeler Chief Development Officer
To view Sitka Biopharma’s complete executive team members history, request access »

Sitka Biopharma Board Members (3)

Name Representing Role Since
Jack Geltosky Ph.D Self Board Member 000 0000
Kristine Swiderek Ph.D Self Board Member 000 0000
Michael Parr Ph.D Sitka Biopharma Co-Founder, President, Chief Scientific Officer & Board Member 000 0000
To view Sitka Biopharma’s complete board members history, request access »

Sitka Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sitka Biopharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GF Securities Investment Bank Minority 000 0000 000000 0
Quark Venture Venture Capital Minority 000 0000 000000 0
CDRD Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view Sitka Biopharma’s complete investors history, request access »